Virax Biolabs Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine Efficacy [Yahoo! Finance]
Virax Biolabs Group Limited - Ordinary Shares (VRAX)
Company Research
Source: Yahoo! Finance
LONDON Feb. 25, 2025 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company") believes that its technology aligns with the United States Department of Health and Human Services' commitment to prioritizing transparency on vaccine efficacy. This initiative is essential for empowering the public with the information needed to make informed health decisions. (PRNewsfoto/Virax Biolabs) Virax Biolabs recognizes the essential role vaccines play in public health and is committed to ensuring vaccine efficacy. The Company asserts the importance of transparency regarding vaccine effectiveness and how individual immune profiles impact vaccination decisions, enabling informed, empowered choices about personal health. Virax Biolabs is positioned to advance vaccine transparency in collaboration with companies developing vaccines. Our cutting-edge technology enables us to provide research-based tools to measure efficacy of the vaccines as well as monitor long term
Show less
Read more
Impact Snapshot
Event Time:
VRAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRAX alerts
High impacting Virax Biolabs Group Limited - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
VRAX
News
- Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement [Yahoo! Finance]Yahoo! Finance
- Virax Biolabs Group Limited Announces Closing of $5 Million Private PlacementPR Newswire
- Virax Biolabs Group Limited Announces $5 Million Private Placement [Yahoo! Finance]Yahoo! Finance
- Virax Biolabs Group Limited Announces $5 Million Private PlacementPR Newswire
- Virax Biolabs' CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to ShareholdersPR Newswire
VRAX
Sec Filings
- 12/18/25 - Form F-3
- 12/18/25 - Form D
- 12/4/25 - Form 6-K
- VRAX's page on the SEC website